Related Experiment Video
Updated: Jul 19, 2026
12:29
Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Antifungal prophylaxis in neutropenia
1Department of Haematology, University Hospital Gasthuisberg, Leuven, Belgium.
Current Opinion in Infectious Diseases
|October 13, 2006
Summary
Antifungal prophylaxis in neutropenic patients lacks strong evidence, except for specific transplant cases. Earlier diagnosis and preemptive strategies may be more effective than widespread prophylactic use.
Area of Science:
- Medical Mycology
- Hematology
- Infectious Diseases
Background:
- Invasive fungal infections (IFIs) are a significant cause of mortality in neutropenic patients.
- Prophylactic antifungal agents are widely used despite limited evidence.
Purpose of the Study:
- To evaluate the efficacy of antifungal chemoprophylaxis in neutropenic patients.
- To assess the current evidence supporting widespread prophylactic use of antifungals.
Main Methods:
- Review of existing literature on antifungal prophylaxis in neutropenic patients.
- Analysis of randomized controlled trials (RCTs) and their limitations.
Main Results:
- Limited firm conclusions can be drawn from available RCTs.
- Fluconazole prophylaxis is effective in allogeneic marrow transplant recipients.
- Current prophylactic practices may be based on insufficient scientific evidence.
Conclusions:
- Antifungal chemoprophylaxis is not strongly supported by science for most neutropenic patients.
- Earlier diagnosis using noninvasive techniques and preemptive strategies show greater promise.
- A shift from liberal prophylactic approaches to targeted strategies is recommended.
Related Concept Videos
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...